Results 51 to 60 of about 5,756 (158)
Cost‐Effectiveness of Ivabradine for Heart Failure in the United States
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016 BackgroundIvabradine is a heart rate–lowering agent approved to reduce the risk of hospitalization for worsening heart failure. This study assessed the cost‐effectiveness of adding ivabradine to background therapy in the United States from the ...
Anuraag R. Kansal +6 more
doaj +1 more source
pharma-kritik, 2008 Mit einer neuen Wirkungsweise erreicht Ivabradin eine ähnliche antianginöse Wirkung wie Atenolol oder Amlodipin. Als Prophylaxe gegen koronare Ereignisse scheint die teure Innovation jedoch nicht wirksam.
openaire +1 more source
The cardiac pacemakers: A paradigm of robustness in evolutionary biology
The Journal of Physiology, Volume 604, Issue 13, Page 5159-5169, 1 July 2026.Abstract figure legend Functional networks in living systems are formed by many thousands of gene products. In association with those networks, several genes (four in this diagram) may be sufficient, each on its own, to ensure that the function occurs. Any one of these may be removed or blocked while leaving the others to continue functioning.
Denis Noble
wiley +1 more source
Рациональная фармакотерапия в кардиологии, 2016 Aim. To study influence of ivabradine as compared with bisoprolol on clinical and hemodynamic indices, exercise tolerance, endothelial function, quality of life (QL) and erectile function in patients with ischemic heart disease. Material and methods.
R. D. Kurbanov +3 more
doaj +1 more source
British Journal of Clinical Pharmacology, Volume 92, Issue 6, Page 1787-1808, June 2026.Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale +5 more
wiley +1 more source
A TRIP‐nano killer silencing the pain pacemakers
The Journal of Physiology, EarlyView.
Elisabetta Cerbai
wiley +1 more source
Cardiovascular Health in Women—Across the Lifespan
Clinical Endocrinology, Volume 104, Issue 6, Page 539-555, June 2026.ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar +5 more
wiley +1 more source
Physiological Reports, Volume 14, Issue 12, June 2026.Abstract Obstructive sleep apnea (OSA) with an apnea‐hypopnea index (AHI) ≥ 15/h increases the cardiovascular disease (CVD) risk in type 1 diabetes (T1D). Cardiovascular autonomic neuropathy (CAN) is a key driver of CVD in diabetes and could be increased by autonomic nervous system (ANS) dysfunction related to OSA.
Marion Faivre +10 more
wiley +1 more source
Rationale and Design of the Türkiye Heart Failure (TURK‐HF) Registry
Clinical Cardiology, Volume 49, Issue 5, May 2026.ABSTRACT Aims The Türkiye Heart Failure (TURK‐HF) registry aims to identify the sociodemographic and clinical characteristics, management strategies, and outcomes of patients with heart failure (HF) and to assess the implementation of evidence‐based HF therapies in Türkiye.
Umut Kocabas +46 more
wiley +1 more source
The Scientific World Journal, 2012 Ivabradine is a novel heart rate lowering agent that inhibits If ionic current in the sinus node and demonstrates antiischaemic and antianginal activity.
Jacek Owczarek +2 more
doaj +1 more source